Endothelial senescence orchestrates the tumor immune microenvironment and immunotherapy response in non-small cell lung cancer.
The response of non-small cell lung cancer to immunotherapy is highly variable and shaped by a heterogeneous tumor microenvironment, yet the stromal drivers remain unclear. We identify senescent endothelial cells (ECs) as key regulators of immunotherapy efficacy. Multi-omics analyses across cancers reveal that ECs repr...